Pharvaris (PHVS) Tax Provisions (2021 - 2026)
Pharvaris' (PHVS) quarterly Tax Provisions came in at -$319738.8 in Q1 2026, little changed YoY from -$321118.8 in Q1 2025, and up 83.49% on a QoQ basis from -$1.9 million in Q4 2025.
Pharvaris (PHVS) Tax Provisions (2021 - 2026) Analysis & Trends
Pharvaris (PHVS) has 6 years of Tax Provisions data on file, last reported at -$319738.8 in Q1 2026.
- Quarterly Tax Provisions changed 0.43% year-over-year to -$319738.8 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$2.3 million (down 15.36% YoY) and the FY2025 annual result came in at -$2.2 million, down 13.7% from the prior year.
- Tax Provisions improved to -$319738.8 in Q1 2026, from -$1.9 million in the prior quarter.
- In the past five years, Tax Provisions ranged from a high of $2.4 million in Q3 2022 to a low of -$2.9 million in Q2 2022.
- A 5-year average of -$170454.8 and a median of -$159231.4 in 2023 frame the typical range for Tax Provisions.
- The widest YoY moves for Tax Provisions: up 3114.12% in 2022, down 81815.03% in 2022.
- Tracing PHVS's Tax Provisions over 5 years: stood at $1.1 million in 2022, then jumped by 34.94% to $1.5 million in 2023, then tumbled by 191.17% to -$1.3 million in 2024, then slumped by 46.27% to -$1.9 million in 2025, then jumped by 83.49% to -$319738.8 in 2026.
- The last three Tax Provisions figures came in at -$319738.8 (Q1 2026), -$1.9 million (Q4 2025), and $212147.3 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 292.00 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 230.90 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 59.00 Mn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 75.45 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 267.73 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 13.31 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 1.90 Mn |
| 10 | Pharvaris | 2.29 Bn | 1.92 Bn | - | 699,974.31 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 699,974.31 |
| Mar 31, 2026 | -319,738.83 |
| Dec 31, 2025 | -1.94 Mn |
| Sep 30, 2025 | 212,147.26 |
| Jun 30, 2025 | -229,541.05 |
| Mar 31, 2025 | -318,370.71 |
| Dec 31, 2024 | -1.32 Mn |
| Sep 30, 2024 | -252,690.42 |
| Jun 30, 2024 | -76,053.03 |
| Mar 31, 2024 | -309,740.21 |
| Dec 31, 2023 | 1.45 Mn |
| Sep 30, 2023 | -159,231.39 |
| Jun 30, 2023 | -102,552.72 |
| Mar 31, 2023 | -65,105.69 |
| Dec 31, 2022 | 1.08 Mn |
| Sep 30, 2022 | 2.42 Mn |
| Jun 30, 2022 | -2.92 Mn |
| Mar 31, 2022 | -43,451.30 |
| Dec 31, 2021 | 102.66 Bn |
| Sep 30, 2021 | -80,415.60 |